Facebook First-in-Class Antibody Drug Conjugate (ADC) Market to Surge to US$5.68 Billion by 2032: The 12.3% CAGR Driving Precision Oncology with Novel Targets and Payloads
Logo

First-in-Class Antibody Drug Conjugate (ADC) Market to Surge to US$5.68 Billion by 2032: The 12.3% CAGR Driving Precision Oncology with Novel Targets and Payloads

クレジット
Avatar
インタビューワー
First-in-Class Antibody Drug Conjugate (ADC) Market to Surge to US$5.68 Billion by 2032: The 12.3% CAGR Driving Precision Oncology with Novel Targets and Payloads-1
シェア
金金の他の作品